6. Treatment Options and Individualized Care

To understand the treatment options available and be able to discuss them appropriately to provide individualised patient care


Full content only available after log-in


6.1.  Knows the different treatment modalities for IBD taking into account disease extent, activity, previous history and complications

6.2.  Knows the modes of delivery of different drug therapies and their advantages and disadvantages

6.3.  Recognises the importance of patient choice in deciding therapy and in helping to ensure adherence

6.4.  Understands the evidence base behind different therapeutic strategies and when they might be appropriate (conventional step care, optimised step up, top down and treat to target)

6.5.  Appreciates the monitoring requirements for specific therapies

6.6.  Appreciates common side effects and complications of therapy, their frequency and how to manage them

6.7.  Appreciates the importance of on-going disease monitoring to confirm efficacy

6.8.  Understands when surgery is the most appropriate therapeutic option

6.9.  Is up to date with the evidence base from current clinical trial and real world data sets for the use of available therapies

6.10.  Has knowledge of the role of optimising therapy including interpretation of therapeutic drug monitoring for conventional and biological therapies

6.11.  Appreciates the role of stopping medical therapies in IBD and the appropriate timing / patient population in whom drugs can be stopped


        
 
Topic:











Programme Phase:



Content Format:








Page: () 1 2 3 4 5 6 7 8 ()

Topic 6 :

Advanced endoscopy will solve - Dilatation and stenting

M. Allez

ECCO'18 Vienna

PPT
 


Topic 6.1 :

Evolution of disease pathways over time in CD early versus late disease

G. Rogler

ECCO'18 Vienna

Webcast + PPT
 


Topic 6.1, 6.2 :

Point of care tests

A. Gils

ECCO'18 Vienna

Webcast + PPT
 


Topic 6.1, 6.2, 6.3, 6.5 :

Medical treatment

K. Katsanos

ECCO'18 Vienna

PPT
 


Topic 6.1, 6.2, 6.4, 6.5 :

Case-based discussion: Optimal management of patient with severe Crohns Disease treated with anti-TNF agents

M. Fitzpatrick

ECCO'18 Vienna

PPT
 


Topic 6.1, 6.2, 6.4, 6.5 :

Clinical grades and scores in IBD

J. Lindsay

ECCO'18 Vienna

PPT
 


Topic 6.11 :

Stopping drugs in children Case-based discussion

J. Kierku?

ECCO'18 Vienna

PPT
 


Topic 6.2 :

How to choose between treatment modalities?

F. Baert

ECCO'18 Vienna

PPT
 


Topic 6.2 :

What is the role of 5-ASA?

G. Mantzaris

ECCO'18 Vienna

PPT
 


Topic 6.2 :

What is the role of immunomodulators?

J. Gisbert

ECCO'18 Vienna

PPT
 


Page: () 1 2 3 4 5 6 7 8 ()